Investigation of angiotensin II/AT1 receptors with carbon-11-L-159,884: A selective antagonist

Journal of Nuclear Medicine

Volumn 39, Issue 7, 1998, Pages 1209-1213

  Szabo, Zsolt ^a   Kao, Pan Fu ^b   Burns, H Donald ^b   Gibson, Raymond E ^b   Hamill, Terence G ^b   Ravert, Hayden T ^b   Kim, Sang Eun ^b   Mathews, William B ^b   Musachio, John L ^b   Scheffel, Ursula ^b   Dannals, Robert F ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NONE

Author keywords

Angiotensin receptors; Carbon 11; Dogs; Kidney; PET; Substituted benzoyl sulfonamides

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CARBON 11; N [[4' [(2 ETHYL 5,7 DIMETHYL 3H IMIDAZO[4,5 B]PYRIDIN 3 YL)METHYL] 2 BIPHENYLYL]SULFONYL]BENZAMIDE; N [[4' [(2 ETHYL 5,7 DIMETHYL 3H IMIDAZO[4,5 B]PYRIDIN 3 YL)METHYL](1,1' BIPHENYL) 2 YL]SULFONYL] 4 METHOXYBENZAMIDE; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DOG; DRUG ACCUMULATION; DRUG BINDING; DRUG SELECTIVITY; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; KIDNEY CORTEX; LIGAND BINDING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ANGIOTENSIN II; ANIMALS; CARBON RADIOISOTOPES; DOGS; FEASIBILITY STUDIES; IMIDAZOLES; KIDNEY CORTEX; PYRIDINES; RADIOLIGAND ASSAY; RECEPTORS, ANGIOTENSIN; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 2642645410     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bernstein KE, Alexander RW. Counterpoint: molecular analysis of the angiotensin II receptor. Endocr Rev 1992;13:381-386.
2. Griendling KK, Murphy TJ, Alexander RW. Molecular biology of the renin-angiotensin system. Circulation 1993;87:1816-1828.
3. Gibson RE, Thorpe HH, Cartwright ME, et al. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys. Am J Physiol 1991;261:F512-F518.
4. Wood AJJ. Angiotensin receptors and their antagonists. N Engl J Med 1996;334:1649-1654.
5. Ferrario CM. The renin-angiotensin system: importance in physiology and pathology. J Cardiovasc Pharmacol 1990;15(suppl 3):S1-S5.
6. Caulfield M, Lavender P, Farrall M, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-1633.
7. Admiraal PJ, Danser AH, Jong MS, Pieterman H, Derkx FH, Schalekamp MA. Regional angiotensin II production in essential hypertension and renal artery stenosis. Hypertension 1993;21:173-184.
8. 1) receptor antagonist. Drug Dev Res 1994;32: 161-171.
9. Chakravarty PK, Naylor EM, Chen A, et al. A highly potent, orally active imidazo [4.5-b]pyridine biphenyl acylsulfonamide (MK-996;L-159,282): a new AT1-selective angiotensin II receptor antagonist. J Med Chem 1994;37:4068-4072.
10. Lappe JT, Toh J, Soffer BA, Goldberg AI, Sweet CS. Efficacy and tolerability of multiple doses of MK-996, an angiotensin II (AII) receptor antagonist, compared to enalapril and to placebo in mild to moderate hypertensive patients [Abstract]. Am J Hypenens 1995;8:180A.
11. 11C]carfentanil. Int J Appl Radiat Isot 1985;36:303-306.
12. 1 receptor imaging. Appl Radiat Isot 1996;47:211-218.
13. Gjedde A. Calculation of glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res 1982;4:237-274.
14. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
15. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985;5: 584-590.
16. Carson RE. Mathematical modeling and compartmental analysis. In: Harbert JC, Eckelman WC, Neumann RD, eds. Nuclear medicine diagnosis and therapy. New York: Thieme; 1996:167-193.
17. Kim SE, Scheffel U, Szabo Z, et al. In vivo labeling of angiotensin II receptors with a carbon-11 labeled selective nonpeptide antagonist. J Nucl Med 1996;37:307-311.
18. 1-like receptor with reduced affinity for DuP753. FEBS Lett 1994;343:146-150.
19. Kivlighn SD, Zingaro GJ, Gabel RA, et al. In vivo pharmacology of a novel AT, selective angiotensin II receptor antagonist. MK-996. Am J Hypertens 1995;8:58-66.
20. Zhuo J, Alcom D, McCausland J, Casley D, Mendelsohn FAO. In vivo occupancy of angiotensin II subtype 1 receptors in rat renal medullary interstitial cells. Hypertension 1994;23:838-843.